Arturo Chiti is a faculty member at San Raffaele Vita-Salute University, specializing in Medical Imaging , Nuclear Medicine , and Oncology . He is affiliated with the disciplinary group focused on Imaging, Radiotherapy, and Neuroradiology (MEDS-22/A), and actively teaches courses such as Radiomics and Radiobiology . His research leverages advanced imaging techniques like PET/MRI and PSMA PET to improve cancer diagnosis, treatment planning, and outcome prediction across multiple oncology domains. Research Trends from 2024-2025 show a focus on optimizing imaging protocols (e.g., SUV parameters, target-to-background ratios), integrating multimodal imaging for surgical guidance, and validating predictive models in Pediatric Brain Tumors Prostate Cancer Hepatocellular Carcinoma Pancreatic Adenocarcinoma Oral Cancer Hodgkin Lymphoma .
Catherine Mansfield is a Senior Strategic Teaching Fellow in the Department of Life Sciences at Imperial College London, teaching undergraduate modules in Biochemistry, Biotechnology, and Biological Sciences. She contributes to curriculum review for first/second-year and postgraduate programs and serves as Biochemistry Year 1 convenor. Her background is in plant developmental biology, and she has worked in widening participation with The Brilliant Club charity. She teaches cell/molecular biology, genetics, and plant biology. Mansfield is a Mental Health First Aider and personal tutor. She holds an MEd from Imperial College London (2024), a PhD from University of East Anglia, and a BA in Natural Sciences (Plant Science) from Cambridge. Her research publications focus on cardiac electrophysiology, biomaterials, and regenerative medicine, with recent work on ventricular fibrillation mechanisms, cardiac patch technology, and stem cell therapies.
David Klimstra, MD, is a Professor of Pathology at Yale School of Medicine. He holds a faculty appointment in the Department of Pathology and is affiliated with the Gastrointestinal (GI) & Liver Pathology division. Previously, he served as Chair of Pathology at Memorial Sloan Kettering Cancer Center (2012–2021) and Chief Medical Officer at Paige AI (2021–2024). His expertise lies in cancer pathology, particularly tumors of the gastrointestinal tract, pancreas, liver, and neuroendocrine systems. Dr. Klimstra’s research focuses on the molecular and proteomic characterization of tumors, integrating computational pathology tools with traditional diagnostic methods. Education: MD from Yale University School of Medicine (1988) Anatomic Pathology Residency at Yale Fellowship in Oncologic Surgical Pathology at MSKCC Research Interests: Pancreatic tumor biology, including precursors to pancreatic cancer Neuroendocrine tumor classification and genomics Application of AI in pathology diagnostics (e.g., lymph node metastases detection) Proteogenomic analysis of gastrointestinal and liver tumors Professional Contributions: Co-founder of Paige AI to advance computational pathology Editor of WHO tumor classification series for gastrointestinal and endocrine organs Mentored dozens of pathology fellows and junior faculty Labs/Teams: Collaborates with interdisciplinary teams in Yale’s Pathology department and computational pathology initiatives.
Dr. Henk Roest is a Researcher in the Department of Surgery at Erasmus University Rotterdam's Faculty of Medicine. With 67 research outputs including articles, posters, and book chapters, his work focuses on developing advanced organotypic models for immunological and oncological research. Ph.D. Student, Rijksuniversiteit Leiden (Dec 1988 - Sept 1993) Post-doc, Erasmus University Rotterdam (Oct 1993 - Jul 1996) Post-doc, Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Aug 1996 - Dec 1999) Dr. Roest's research spans organoid systems with particular expertise in cholangiocyte biology, lymph node immunology, and cancer resistance mechanisms. His work bridges basic cell biology with clinical applications in transplantation medicine and oncology, using advanced cell culture techniques to model complex biological systems. Analysis of his recent publications reveals a consistent focus on developing physiologically relevant models that better mimic human tissue function. His work on lymph node models, cholangiocarcinoma organoids, and lymphoma-on-chip systems demonstrates methodological innovation across immunology and oncology. His research on nanoplastics effects on marine mammals shows the versatility of his cell culture expertise. Dr. Roest has supervised at least one student as indicated by the 'Supervised Work (1)' notation in his profile. His collaborative network spans multiple institutions with international research partnerships, reflecting the interdisciplinary nature of his work in biomedical modeling.
Dale Fournier is an Assistant Professor in the Physical Therapy department at Clarkson University, specializing in musculoskeletal health research with particular focus on spine disorders. His transdisciplinary approach bridges laboratory research and clinical practice, emphasizing the use of medical imaging for conditions like diffuse idiopathic skeletal hyperostosis (DISH). Education includes: Ph.D. in Health and Rehabilitation Sciences (Physical Therapy) - University of Western Ontario Master of Physical Therapy (M.PT.) - University of Western Ontario M.Sc. in Anatomy and Cell Biology - University of Western Ontario B.Sc. Honours in Kinesiology - University of Western Ontario Research focuses on musculoskeletal health, particularly spinal pathologies including DISH, back pain, and arthritis. Work integrates medical imaging (CT, radiography), clinical study design, and basic science approaches using animal models and histological analysis. Current investigations examine ectopic mineralization processes and their clinical implications. Awards recognizing scientific contributions: 2022 Dr. Suzanne Bernier Award in Skeletal Biology 2019 Robert C. Buck Master's of Science Award 2019-2022 Arthritis Society Graduate Ph.D. Award
Satish E. Viswanath is an Associate Professor at Case Western Reserve University, holding joint appointments in the Case School of Engineering and School of Medicine. He leads research in AI-driven medical imaging and radiomics, focusing on gastrointestinal cancers and digestive diseases. His work integrates imaging, pathology, and molecular data to develop predictive models for treatment response and disease progression. Viswanath has authored over 50 peer-reviewed papers, 100 conference contributions, and holds 10 patents. He serves on editorial boards for medical imaging journals and holds senior memberships in IEEE, SPIE, and the National Academy of Inventors. Education: PhD in Biomedical Engineering (Rutgers University, 2012), MSc in Electronics and Electrical Engineering (University of Aberdeen, 2005), BE in Electronics and Instrumentation (University of Mumbai, 2004). Research Interests: Radiomics, AI in oncology, cross-modal data fusion, and translational imaging tools for clinical decision support. His lab develops AI tools for imaging-based biomarkers in colorectal, renal, and prostate cancers, with applications in treatment planning and response monitoring. Awards: 2023 SIIM Imaging Informatics Innovator Award, 2023 Fulbright Specialist Award, 2022 SPIE Best Paper Award, and NIH/DoD grants since 2016. Leadership roles include co-directing the Center for AI Enabling Discovery in Disease Biology (AID2B). Key Projects: Radiomic models for Crohn’s disease fibrosis/inflammation, MRI-based response assessment in rectal cancer, and AI-driven renal imaging in pediatric hydronephrosis.
Prof. Dr. Aurel Perren is Vice Dean for Digitalization at the Faculty of Medicine, University of Bern , and Head of the Institute of Pathology . His research focuses on neuroendocrine tumors, pancreatic cancer, and digital pathology applications. Current academic roles: Vice Dean Digitalization, Faculty of Medicine, University of Bern Institutional affiliation: Institute of Pathology, University of Bern Research Interests : Aurel Perren's work spans pancreatic neuroendocrine neoplasms , thyroid tumor heterogeneity , and AI-driven medical diagnostics . Key areas include metabolic tumor profiling , immune microenvironment dynamics , and digital pathology implementation . Scientific Collaborations & Tools : He contributes to ENETS position statements and develops deep learning-based diagnostic workflows for lymph node metastases and tumor cell fraction quantification. His team investigates 3D tumor mapping via micro-CT radiomics and molecular subtyping of neuroendocrine tumors. Publications & Projects : Recent articles highlight MCT transporter inhibition strategies, molecular subtyping of PanNETs, and validation of NETest liquid biopsy for high-grade neuroendocrine neoplasms. Current projects focus on spatial immune heterogeneity and personalized tumoroid therapies.
Dr Ross Porter serves as a CRUK TRACC Clinical Research Training Fellow within the School of Cancer Sciences at the University of Glasgow, focusing on the intersection of inflammatory bowel disease (IBD) and gastrointestinal oncology. His research integrates clinical practice with translational science to address critical gaps in colorectal cancer surveillance and biomarker development for IBD patients. Porter's research interests center on Inflammatory Bowel Disease-associated colorectal carcinogenesis , with specific expertise in MLH1-deficient cancers , HMGB1 biomarker expression , and immune microenvironment characterization . His work leverages advanced methodologies including QuPath digital pathology algorithms , human tissue-derived organoid models , and immunohistochemical profiling to identify clinically actionable biomarkers for risk stratification and therapeutic targeting. Analysis of Porter's publication trends reveals a consistent focus on translational GI oncology , with 75% of his recent work examining IBD-cancer connections. Key themes include biomarker validation (HMGB1, c-MET, LL-37), endoscopic surveillance optimization, and organoid-based disease modeling. His research demonstrates strong clinical applicability, particularly in refining surveillance protocols for high-risk IBD populations. CRUK TRACC Clinical Research Training Fellowship Cancer Research UK Training Fellowship Porter's research is primarily funded through his CRUK fellowship, which supports his investigation into molecular mechanisms linking chronic inflammation to neoplastic progression. His collaborative work spans multiple institutions across Europe, with significant contributions to multicenter studies like the PORCSE Study on Crohn's disease recurrence. Current projects focus on developing digital pathology tools for automated cancer detection in IBD patients and characterizing immune-cold phenotypes in colorectal cancer. Porter actively collaborates with the Glasgow Cancer Research UK Centre and participates in tissue-based research using organoid models derived from patient samples. His work interfaces with clinical endoscopy units and pathology departments to validate biomarkers in real-world settings, emphasizing rapid translation from bench to bedside.
Dr. Daniel Förnvik is an Associate Professor at the Medical Radiation Physics department of Lund University, affiliated with the Lund University Cancer Centre (LUCC). His research focuses on breast cancer imaging, particularly through digital breast tomosynthesis (DBT), mammography, and artificial intelligence applications in radiology. He actively contributes to clinical research projects and collaborates internationally on cancer detection and screening optimization. Key Research Areas: Breast cancer diagnostics, AI-driven imaging analysis, radiation physics, tumor growth modeling Projects: Malmö Breast Tomosynthesis Screening Trial, NeoDense study, AI integration in mammography His recent work explores deep learning for chemotherapy response monitoring, abbreviated MRI integration with DBT, and breast density impacts on screening accuracy. Articles show expertise in overdiagnosis prevention, image quality assessment, and multi-omics approaches combining ctDNA analysis with radiomics. As a Principal Investigator, he supervises doctoral students Johannes Olinder and Andreas Bjerkén in projects examining DBT implementation and AI applications in breast imaging. Though no explicit awards are listed, his 51+ publications and sustained 2010-2025 research output demonstrate significant contributions to medical radiation physics and oncology imaging.
Matthew Williams, DVM, DACVP, serves as an Associate Professor at the College of Veterinary Medicine, Mississippi State University. His academic focus is veterinary clinical pathology, with extensive expertise in hematology and cytology for diverse animal species including canines, felines, and exotic animals. Education: Residency in Clinical Pathology, Colorado State University (2004-2007) Doctor of Veterinary Medicine (DVM), Tuskegee University (2001) Bachelor of Science in Medical Technology, University of Alabama at Birmingham (1996) Dr. Williams' research program emphasizes diagnostic veterinary pathology, particularly in hematological analysis, cytological interpretation, and blood transfusion protocols. His work bridges clinical practice with laboratory diagnostics, developing case-based methodologies that enhance disease identification across multiple species. He has pioneered techniques in respiratory diagnostics and neoplastic disease characterization, contributing significantly to veterinary diagnostic standards. Analysis of his 11 publications (2006-2023) reveals consistent innovation in veterinary clinical pathology, with particular emphasis on neurological disorders, oncological conditions, and transfusion medicine. His research demonstrates a progression from foundational case reports to sophisticated methodological studies, reflecting deepening expertise in diagnostic instrumentation and species-specific pathology. Scientific Awards: Diplomate of the American College of Veterinary Pathologists (DACVP) Dr. Williams actively mentors veterinary students through clinical rotations and specialized instruction, while his extensive conference presentations demonstrate commitment to practitioner education. His 15+ lectures at national venues including the Southern Veterinary Conference and American College of Veterinary Pathologists meetings have established him as a key educator in hematology and cytology techniques. Though specific grant funding isn't detailed, his sustained publication record indicates successful research support. He contributes to Mississippi State University's outreach initiatives including VetAspire and community engagement programs, extending his expertise beyond academia to strengthen veterinary practice nationwide.
Dr. Sevan Harput serves as an Associate Professor in Electrical and Electronic Engineering at London South Bank University (LSBU), where he joined in 2019. He leads Biomedical Imaging, Monitoring and Treatment research within the REACT Innovation Centre, Bioscience and Bioengineering Research Centre, and Digital x Data Research Centre. Harput also heads the South Bank Applied BioEngineering Research (SABER) group, focusing on translating engineering innovations into clinical applications. Harput earned his PhD in Electronic and Electrical Engineering from the University of Leeds (2009-2013). He subsequently worked as a Research Fellow at Leeds (2013-2016), then as a Research Associate at Imperial College London (2016-2019), with additional visiting researcher experience at King's College London. His academic journey demonstrates continuous progression in ultrasound imaging research. His research focuses on developing novel imaging and sensing technologies using ultrasonic frequencies, with current projects emphasizing high frame-rate ultrasound imaging, super-resolution methods, 3D ultrasound, signal processing for biomedical applications, and ultrasound sensor development. He leads the SPE3D Ultrasound research lab ( https://sevanharput.github.io/ ), pioneering innovative ultrasound approaches. His fingerprint reveals expertise in 3D Localization, Microvascular Blood Flow, Ultrasonics Engineering, Transducer Engineering, Cortical Bone Thickness, and Ultrasound Super-resolution Imaging. Harput's recent publications demonstrate significant advancement in ultrasound technology for medical diagnostics, particularly in bone health assessment and microvascular imaging. His work bridges engineering innovation with clinical applications, with strong emphasis on super-resolution techniques, deep learning applications to ultrasound data, and novel transducer designs. The research shows progression from fundamental physics to practical clinical implementations. Secured research funding totaling over £1.2 million as PI, Co-I and researcher (£163k as PI) Industrial Consultancy valued at £70k with partners including Dragerwerk AG, Clinical Technology Ltd., Tribosonics, and Plexus Corp Co-Inventor of patent 'Apparatus and method for manipulating entrained particles' Funding from EPSRC, Royal Society, and GCRF As an educator, Harput teaches Digital Signal Processing, Digital System Design, and Biomedical Electronics. His research contributes to UN Sustainable Development Goals related to health and well-being. With 70 research outputs spanning from 2008 to 2024, his work shows consistent productivity and evolution toward increasingly clinically relevant applications, particularly in bone health monitoring and cancer diagnostics through advanced ultrasound techniques.
Carlos António Cardoso Fernandes is a Full Professor at the Department of Electrical and Computer Engineering (DEEC) at Instituto Superior Técnico (IST), University of Lisbon, and a Senior Researcher at the Instituto de Telecomunicações (IT). He is the Thematic Line Coordinator for Wireless Technologies and leads the Antennas and Propagation Group. His research focuses on millimeter-wave antennas, metamaterials, medical microwave imaging, and satellite systems, with applications in IoT, body-area networks, and environmental monitoring. Education and Career: PhD in Electrical and Computer Engineering, IST (1990) Agregação (Habilitation), IST (2002) Full Professor since 2006 Past Vice-President of DEEC (2003–2004) Past Board Member of IT (2009–2024) Research Interests: Millimeter-wave antennas for 5G/6G and satellite communications Metamaterials for lens antennas and superlensing Medical microwave imaging for cancer screening RFID/UWB antennas for IoT and localization Radiowave propagation in complex environments Publications & Impact: Over 400 peer-reviewed papers (including 100+ journal articles), 6,000+ citations, and an h-index of 44. Key contributions include patents on antennas for medical imaging and satellite systems, and leadership in EU/ESA projects like ISTSat-1 (CubeSat mission). Awards & Recognition: Lifetime Achievement Award by PTSpace (2024) Prémio UTL/Santander Totta (2011) Top 2% Most-Cited Scientists (Stanford University, 2023/2024) Correspondent Member, Lisbon Academy of Sciences Students & Mentorship: Supervisor of 12 PhD and nearly 50 MSc students, with topics ranging from antenna design to medical imaging systems.
David Abia-Trujillo, MD, MB, is a Research Fellow in Pulmonary Medicine at Mayo Clinic, specializing in interventional pulmonology and critical care. His clinical focus includes advanced COPD, central airway obstruction, pleural disease, and diagnostic interventions for pulmonary nodules. He trained in Internal Medicine at Morristown Medical Center, Pulmonary & Critical Care at Mayo Clinic (Jacksonville, FL), and Interventional Pulmonology at Harvard's Beth Israel Deaconess/Mass General Hospital program (Boston, MA). 2022: Advanced Fellowship, Harvard Medical School Affiliates 2021: Pulmonary & Critical Care Fellowship, Mayo Clinic 2018: Internal Medicine Residency, Morristown Medical Center 2012: MD, Autonomous University of Querétaro, Mexico His research explores robotic-assisted bronchoscopy, shape-sensing technology, and mobile Cone-Beam CT for lung cancer diagnosis, pleural disease, and airway collapse management. Recent work emphasizes procedural optimization, diagnostic accuracy, and innovative stenting techniques. Scientific accolades include the 2023 Mayo Clinic Top Performer Award , 2022 Catalyst Award , and multiple peer-reviewed publications in journals like Lung Cancer , Thorax , and Respiration . Professional memberships span the European Association for Bronchology and the American Thoracic Society.
Dr. Andre M. Oliveira is a distinguished Medical Geneticist and Pathologist at Mayo Clinic in Rochester, Minnesota. He holds dual appointments in the Department of Laboratory Medicine and Pathology with a focus on Anatomic Pathology. Dr. Oliveira is a leading expert in molecular pathology of sarcomas and bone tumors, with particular expertise in gene fusions and oncogenes like USP6. His educational background includes: PhD in Pathology from Escola Paulista de Medicina, Universidade de São Paulo (2010) Postgraduate Fellowship in Cytogenetics from Mayo Medical School (2005) Residency in Molecular Genetic Pathology from Mayo School of Graduate Medical Education (2004) Postgraduate Fellowship in Clinical Molecular Genetics from Brigham and Women's Hospital and Harvard (2004) MD from Federal University of Rio de Janeiro (1995) Dr. Oliveira's research primarily focuses on the molecular mechanisms of sarcomas and bone tumors, with special emphasis on USP6 oncogene and its role in tumor development. His work has significantly advanced understanding of gene fusions in sarcomas, particularly in aneurysmal bone cysts and nodular fasciitis. He has pioneered research showing how USP6 functions both as an oncogene and tumor suppressor depending on context, with implications for immunotherapy approaches in Ewing sarcoma. His recent publications demonstrate a strong focus on molecular diagnostics for sarcomas, with particular attention to developing clinical next-generation sequencing assays for detecting gene fusions. His work spans from basic molecular mechanisms to clinical applications, with an increasing emphasis on how molecular findings can inform treatment approaches, particularly in the realm of immunotherapy. Dr. Oliveira has received several prestigious awards throughout his career: Hobart K.B. Allenbach Award for Outstanding Resident in Pathology (2001) Pediatrics Award from Universidade Federal do Rio de Janeiro (1995) Doctor of Medicine cum laude from Universidade Federal do Rio de Janeiro (1995) Internal Medicine Award from State Secretary of Health of Rio de Janeiro (1995) Internal Medicine Award from Brazilian Navy Army (1995) As a senior researcher at Mayo Clinic, Dr. Oliveira has mentored numerous trainees and junior faculty in molecular pathology. His laboratory has been consistently funded through NIH and foundation grants supporting research on sarcoma genetics and molecular diagnostics. He serves as a principal investigator on multiple studies focused on developing molecular diagnostic tools for sarcomas and understanding the pathogenesis of rare bone and soft tissue tumors. Dr. Oliveira leads a research team within the Department of Laboratory Medicine and Pathology that specializes in molecular analysis of sarcomas. His laboratory utilizes advanced genomic techniques including next-generation sequencing to identify novel gene fusions and molecular markers that can improve diagnosis and treatment of sarcomas. The team collaborates extensively with surgical pathologists, orthopedic oncologists, and medical oncologists to translate molecular findings into clinical practice.
Dr. Mee Ling Munier is a Senior Lecturer and Group Leader at the Kirby Institute within the University of New South Wales (UNSW) . Her work focuses on characterizing immune responses to vaccination and infection , particularly in human lymph nodes and peripheral blood. She leads the Vaccine Immunogenomics group within the Immunovirology and Pathogenesis Program (IVPP) , utilizing fine needle biopsy (FNB) techniques to study post-vaccination immune dynamics. UNSW Medicine & Health Kirby Institute Vaccine Immunogenomics Group
